Crossmark

Using urine metabolomics to understand the pathogenesis of infant respiratory syncytial virus (RSV) infection and its role in childhood wheezing

Published Online: 2018-10-01

Published Print: 2018-10

Authors

Turi, Kedir N.

Romick-Rosendale, Lindsey

Gebretsadik, Tebeb

Watanabe, Miki

Brunwasser, Steven

Anderson, Larry J.

Moore, Martin L.

Larkin, Emma K.

Peebles, Ray Stokes Jr.

Hartert, Tina V.
Funding

Funding for this research was provided by:

National Institute of Allergy and Infectious Diseases (U19AI95227)

National Institute of Allergy and Infectious Diseases (R21HD087864)

National Institute of Allergy and Infectious Diseases (K24 AI 77930)

National Institute of Allergy and Infectious Diseases (T32HL087738)
License Information

Text and Data Mining valid from 2018-10-01

Version of Record valid from 2018-10-01
More Information

Article History

Received: 14 March 2018

Accepted: 21 September 2018

First Online: 1 October 2018

Compliance with ethical standards

:

: Dr. Hartert has previously served as a consultant to Novavax and Regeneron. Dr. Kedir N Turi, Dr. Lindsey Romick-Rosendale, Tebeb Gebretsadik, Dr. Miki Watanabe, Dr. Steven Brunwasser, Dr. Larry J Anderson, Dr. Martin L Moore, Dr. Emma K Larkin, Dr. Ray Stokes Peebles and Dr. Tina V. Hartert have no conflicts of interest.

: This study was approved by the ethical committee of Vanderbilt University Medical Center, Nashville TN.

: Informed written consent was obtained from the parent of each infant for study participation.

Document is current